---
title: "Rhythm Pharmaceuticals Executives Sell Shares"
date: "2025-02-12 10:50:00"
summary: "Reporter NameRelationshipTypeAmountSEC FilingSmith Hunter CChief Financial OfficerSell$74,533Form 4Cramer Pamela J.Chief Human Resources OfficerSell$40,314Form 4Lee Jennifer KaydenEVP, Head of North AmericaSell$305,845Form 4Shulman JosephChief Technical OfficerSell$45,663Form 4Rhythm Pharmaceuticals has seen a series of share sales by its executives, as reported in recent SEC Form 4 filings. Smith Hunter C, the Chief Financial..."
categories:
  - "TradingView"
lang:
  - "en"
translations:
  - "en"
tags:
  - "TradingView"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

| Reporter Name | Relationship | Type | Amount | SEC Filing |
| --- | --- | --- | --- | --- |
| Smith Hunter C | Chief Financial Officer | Sell | $74,533 | [Form 4](https://www.sec.gov/Archives/edgar/data/1649904/000110465925011674/xslF345X05/tm256299-1_4seq1.xml) |
| Cramer Pamela J. | Chief Human Resources Officer | Sell | $40,314 | [Form 4](https://www.sec.gov/Archives/edgar/data/1873517/000110465925011676/xslF345X05/tm256299-2_4seq1.xml) |
| Lee Jennifer Kayden | EVP, Head of North America | Sell | $305,845 | [Form 4](https://www.sec.gov/Archives/edgar/data/1801372/000110465925011677/xslF345X05/tm256299-3_4seq1.xml) |
| Shulman Joseph | Chief Technical Officer | Sell | $45,663 | [Form 4](https://www.sec.gov/Archives/edgar/data/1909855/000110465925011679/xslF345X05/tm256299-4_4seq1.xml) |

Rhythm Pharmaceuticals has seen a series of share sales by its executives, as reported in recent SEC Form 4 filings.

Smith Hunter C, the Chief Financial Officer, sold 1,296 shares at prices of $57.51 and $57.53, totaling $74,533. Post-transaction, Hunter directly owns 106,295 shares of the company.

Pamela J. Cramer, the Chief Human Resources Officer, sold 701 shares at prices ranging from $57.51 to $57.54, with a total sale amount of $40,314. Following the sales, Cramer directly owns 16,891 shares.

Jennifer Kayden Lee, EVP, Head of North America, executed sales of 5,216 shares on February 10 and 11, 2025, at weighted average prices between $57.5 and $59.3408, totaling $305,845. Lee now directly owns 5,413 shares. These transactions were conducted under a Rule 10b5-1 trading plan adopted on August 8, 2024.

Joseph Shulman, the Chief Technical Officer, sold 794 shares at prices ranging from $57.51 to $57.54, totaling $45,663. Following these transactions, Shulman directly owns 6 shares of the company.

[TradingView](https://www.tradingview.com/news/tradingview:04eff7213c83e:0-rhythm-pharmaceuticals-executives-sell-shares/)
